Total Funding
2
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
White Square Chemical commercializes DCP and PNF-based patented and non-patented applications.
Nicholas Hawkins: CEO & Board Director
About the Company
White Square Chemical commercializes DCP and PNF-based patented and non-patented applications. It creates polyphosphazene products with properties not previously attainable. These materials have the capacity to bioerode for tissue and bone regeneration, sustain controlled release of drugs and vaccines, speed communications with non-linear optical
devices, and produce o-rings that do not freeze when exposed to liquid oxygen.
White Square Chemical offers NOVUS, a long-standing and proven FDA-approved denture liner that WSQ intends to commercialize through a series of investments and partnerships.
The company was founded in 2012 and is headquartered in Tavernier, Florida.
